Additionally, GBE1 blockade could promote the secretion of CCL5 and CXCL10 to recruit CD8+ T lymphocytes to the tumor microenvironment via the IFN-I/STING signaling pathway, accompanied by upregulation of PD-L1 in LUAD cells (6). This evidence concerns the gene GBE1 and neoplasm.